NovaBay Pharmaceuticals (NBY) Stock Rockets On COVID-19 News

NovaBay Pharmaceuticals NBY Stock News

NovaBay Pharmaceuticals, Inc. (NYSEAMERICAN: NBY) is running for the top in the market this morning, and for good reason. The company anounced results from laboratory tests showing that its disinfectant product kills the strain of the coronavirus at the center of today’s pandemic. Here’s what’s going on:

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

NBY Stock Gains On Positive Laboratory Tests

In the press release, NovaBay Pharmaceuticals provided the results from an independent third-party laboratory that assessed Avenova, the company’s disinfectant. In the release, NBY said that the third party test show that its proprietary formulation of pure hypochlorous acid kills SARS-CoV-2.

Importantly, NBY said that it will be submitting the test results to the United States Environmental Protection Agency with the goal of the EPA adding Avenova to the approved list of disinfectants for use against SARS-CoV-2.

In the release, the comapny said that the study was designed to determine Avenova’s ability to kill SARS-CoV-2 on a hard surface. Testing was carried out at room temperature. During the test, Avenova was sprayed on the surface froma distance of six to eight inches until the surface was thoroughly wet. From there, within 60 seconds, the disinfectant was proven to fully inactivate the virus.

In a statement, Justin Hall, CEO at NBY, had the following to offer:

Since Avenova’s inception, we have known it to be a powerful antimicrobial spray solution, effective against all types of pathogens, including a wide variety of viruses, bacteria, and fungi. Now we have results from a highly reputable independent laboratory confirming Avenova kills the coronavirus that causes COVID-19.

Most COVID-19 transmission is likely due to person-to-person contact as respiratory droplets containing the virus spread through the air by speaking or even breathing, and reach others in close proximity. These large droplets transmit the virus by entering the body typically through the eyes, nose or mouth.

Avenova, formulated with our pure, FDA-cleared hypochlorous acid, is completely non-toxic and is safe for use on all skin surfaces, including delicate facial skin around eyes, nose and mouth. As a cautionary note, I would like to warn consumers that not all hypochlorous acid products are alike. Some are not designed for use on skin the way Avenova is, and others are not as pure and should not be used on skin on a daily basis. Additionally, some hypochlorous acid products are not of a high pharmaceutical grade like ours and may not maintain a sufficiently high concentration of hypochlorous acid to kill SARS-CoV-2.

This News Is Exciting

At the moment, we’re living in a COVID-19 pandemic riddled world. While the economy is beginnig to reopen, facemasks are still an important part of life, we’re not getting anywhere near strangers, and visitations to our loved ones in nursing homes have been slim due to fears of getting the elderly sick.

The bottom line is that we’re still far from out of the woods.

Novabay is one of several companies in the fight to bring some normalcy back to the United States and the world. With the company’s disinfectant being proven to kill SARS-CoV-2, the demand for the product is likely to head for the top as consumers, businesses, medical offices, government agencies, and other entities look for new ways to protect themselves and their staff from infection with COVID-19. As a result, NBY stock should be watched incredibly closely!

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Don’t Miss The Next Big Story

Join our free mailing list below to receive real-time news alerts!

Subscribe Today!

* indicates required

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.